Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Phase: N/A Priority: Normal
NCT ID: NCT05844436 Org: User:
Start: - End: - Due: -

Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes

Phase: N/A Priority: Normal
NCT ID: NCT02871492 Org: User:
Start: 11/29/16 End: 10/16/17 Due: 10/16/18

Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir

Phase: N/A Priority: Normal
NCT ID: NCT05513625 Org: User:
Start: 07/13/20 End: 10/13/20 Due: 10/13/21

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03073967 Org: User:
Start: 05/08/17 End: 11/30/25 Due: 11/30/26

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Phase: N/A Priority: Normal
NCT ID: NCT01658826 Org: User:
Start: 10/31/12 End: 07/31/13 Due: 07/31/14

Thorough QT/QTc of Pritelivir in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05671029 Org: User:
Start: 12/04/22 End: 05/18/23 Due: 05/18/24

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Phase: N/A Priority: Normal
NCT ID: NCT01063829 Org: User:
Start: 03/31/10 End: 12/31/11 Due: 12/31/12

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Phase: N/A Priority: Normal
NCT ID: NCT01047540 Org: User:
Start: 03/31/10 End: 03/31/11 Due: 03/31/12